Brodalumab treatment improved clinical signs and symptoms in Phase 2 psoriatic arthritis study published in The New England Journal Of Medicine
Phase 3 program underway to further assess Brodalumab as potential…
12 June 2014 | By Amgen
Phase 3 program underway to further assess Brodalumab as potential treatment for people living with psoriatic arthritis...